Dr Reddys Laboratories (RDY) EBITDA Margin Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) EBITDA Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 898.00 |
| Mar 31, 2023 | 1,376.00 |
| Sep 30, 2022 | 3,763.00 |
| Jun 30, 2021 | 762.00 |
| Mar 31, 2021 | 56.00 |
| Sep 30, 2020 | -3,544.00 |
| Sep 30, 2019 | -3,253.00 |
| Mar 31, 2019 | 12.00 |
| Dec 31, 2018 | 1,325.00 |
| Sep 30, 2018 | 1,490.00 |
| Jun 30, 2018 | -979.00 |
| Dec 31, 2017 | -822.00 |
| Sep 30, 2017 | 113.00 |
| Dec 31, 2016 | -791.00 |
| Sep 30, 2016 | 1,918.00 |
| Mar 31, 2016 | 2,073.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | -2,644.00 |
| Jun 30, 2015 | 252.00 |
| Dec 31, 2014 | 9.00 |